Publications


Our publications span analytical platform development (CE–MS and complementary MS), software and data standards, and application-driven glyco(proteo)mics—with a strong emphasis on biomarker-oriented oncology research. For a curated narrative of our application work (including PSA, PAP, and CEA highlights), see the Applications page; the sections below group publications by theme to help you quickly find work relevant to your question or sample type.

This section highlights our most recent manuscripts (preprints/accepted/in press) alongside field-shaping reviews, reporting guidelines, and software outputs. It provides a quick entry point to what’s new, what we contribute to community standards, and how we make glyco(proteo)mics analysis more scalable.

General

Here we present analytical and workflow innovations that improve sensitivity, specificity, and structural resolution in glyco(proteo)mics, with a strong focus on CE–MS and complementary MS strategies. These papers form the technical foundation for our application-driven studies and assay development.

Method Development

This section collects our biomarker-oriented oncology work, spanning protein-of-interest assays (PSA, PAP, CEA/CEACAM5), biofluid and cell-model studies, and cancer-relevant glycosylation signatures. The emphasis is on translating glycosylation and proteoform information into interpretable readouts for detection, stratification, and monitoring.

Cancer Biomarkers & Oncology Applications

These publications focus on glycosylation in immune-mediated and inflammatory contexts, including systemic signatures and immunoglobulin glycosylation. Together, they illustrate how glycan remodeling tracks immune state and can support biomarker discovery beyond oncology.

Immunology, Inflammation & Systemic Disease

Beyond peer-reviewed papers, we contribute through patent applications, theses, book chapters, and technical/application notes that translate methods into practice and support community uptake. These outputs reflect both applied innovation and educational efforts in glyco(proteo)mics.

Other Ouputs

    • Cobbaert, C. Kroeniger, K., Lageveen-Kammeijer, G.S.M., Nouta, J., Rolny, V., Ruhaak, R., Swiatek-de Lange, M., Tabares, G., Burgt, Y. van der, Wuhrer, M. Methods for management of prostate cancer. US20250116670A1 (18908787). (2025)

    • Lageveen-Kammeijer, G.S.M. Unravelling the sugar-coating of prostate-specific antigen: Method development and its application to prostate cancer research. Thesis (2019). ISBN: 978-94-6380-249-9

    • Wang, W., Wang, W. and Lageveen-Kammeijer, G.S.M. (2022) CE-MS approaches for glyco(proteo)mic analysis. CE-MS for Proteomics and Metabolomics, Wiley-Verlag

    • Wang, W. and Lageveen-Kammeijer, G.S.M. (2022) High Sensitivity Glycoproteomic Analysis of Biological Samples by CE-ESI-MS. Capillary Electrophoresis-Mass Spectrometry: Methods and Protocols, Methods in Molecular Biology, Springer Nature (In Press)

    • Protein Metrics, Intact Profiling and Visualization of Urinary Prostate-Specific Antigen (PSA) Profiles from Pooled and Individual Patient Samples (Application note)

    • Kammeijer, G.S.M., Kohler, I., Jansen, B.C., Hensbergen, P.J., Mayboroda, O.A., Falck, D., Lock, S., Wuhrer, M. Improved CESI-MS sensitivity and repeatability in Glycopeptide Analysis using a Dopant Enriched Nitrogen Gas.